tetano
Editor, Senior Moderator
Cell Immunol
. 2020 Dec 11;360:104256.
doi: 10.1016/j.cellimm.2020.104256. Online ahead of print.
Deep sequencing reveals the skewed B-cell receptor repertoire in plaques and the association between pathogens and atherosclerosis
Shucui Zhang[SUP] 1 [/SUP], Shigang Zhang[SUP] 2 [/SUP], Zongwei Lin[SUP] 1 [/SUP], Xinjie Zhang[SUP] 3 [/SUP], Xinyao Dou[SUP] 3 [/SUP], Xiaoming Zhou[SUP] 4 [/SUP], Xiaowei Wang[SUP] 1 [/SUP], Zhe Wang[SUP] 5 [/SUP], Qunye Zhang[SUP] 6 [/SUP]
Affiliations
Abstract
The immune/inflammatory responses regulated by B cells are the critical determinants of atherosclerosis. B-cell receptor (BCR) plays pivotal roles in regulating B cell function. However, the composition and molecular characteristics of the BCR repertoire in atherosclerotic patients have not been fully elucidated. Herein we analyzed BCR repertoire in circulation and plaques of atherosclerotic patients by sequencing the BCR heavy chain complement determining region 3 (BCRH CDR3). Our data showed that in plaques, BCR repertoire was dramatically skewed and their combinations and diversity were significantly decreased, while the frequency of public and dominant B-cell clones was markedly increased. Additionally, BCRH CDR3 in plaques had higher positive selection pressure than that in the peripheral blood of normal subjects and atherosclerotic patients. Moreover, the BCRH CDR3 of some B cell clones specifically expanded in plaques were similar to that of antibodies which recognized certain pathogens including Influenza A virus, implying the possibility of the association between pathogens and atherosclerosis. The present study contributed to understand the roles of B cells in atherosclerosis. The design of specific antibodies based on the B cell clones specifically expanded in plaques might yield useful tools to reveal the pathogenesis of atherosclerosis, assess or alleviate the progression of atherosclerosis.
Keywords: Atherosclerosis; B-cell receptor; Complement determining region 3; Immune repertoire; Next-generation DNA sequencing.
. 2020 Dec 11;360:104256.
doi: 10.1016/j.cellimm.2020.104256. Online ahead of print.
Deep sequencing reveals the skewed B-cell receptor repertoire in plaques and the association between pathogens and atherosclerosis
Shucui Zhang[SUP] 1 [/SUP], Shigang Zhang[SUP] 2 [/SUP], Zongwei Lin[SUP] 1 [/SUP], Xinjie Zhang[SUP] 3 [/SUP], Xinyao Dou[SUP] 3 [/SUP], Xiaoming Zhou[SUP] 4 [/SUP], Xiaowei Wang[SUP] 1 [/SUP], Zhe Wang[SUP] 5 [/SUP], Qunye Zhang[SUP] 6 [/SUP]
Affiliations
- PMID: 33360167
- DOI: 10.1016/j.cellimm.2020.104256
Abstract
The immune/inflammatory responses regulated by B cells are the critical determinants of atherosclerosis. B-cell receptor (BCR) plays pivotal roles in regulating B cell function. However, the composition and molecular characteristics of the BCR repertoire in atherosclerotic patients have not been fully elucidated. Herein we analyzed BCR repertoire in circulation and plaques of atherosclerotic patients by sequencing the BCR heavy chain complement determining region 3 (BCRH CDR3). Our data showed that in plaques, BCR repertoire was dramatically skewed and their combinations and diversity were significantly decreased, while the frequency of public and dominant B-cell clones was markedly increased. Additionally, BCRH CDR3 in plaques had higher positive selection pressure than that in the peripheral blood of normal subjects and atherosclerotic patients. Moreover, the BCRH CDR3 of some B cell clones specifically expanded in plaques were similar to that of antibodies which recognized certain pathogens including Influenza A virus, implying the possibility of the association between pathogens and atherosclerosis. The present study contributed to understand the roles of B cells in atherosclerosis. The design of specific antibodies based on the B cell clones specifically expanded in plaques might yield useful tools to reveal the pathogenesis of atherosclerosis, assess or alleviate the progression of atherosclerosis.
Keywords: Atherosclerosis; B-cell receptor; Complement determining region 3; Immune repertoire; Next-generation DNA sequencing.